文献速递腹部MR

肝脏磁共振磁敏感加权成像(SWI)与T2* mapping在存在脂肪变性和纤维化时的比较

Liver MRI susceptibility-weighted imaging (SWI) compared to T2* mapping in the presence of steatosis and fibrosis.
PubMed 文献 · Eur J Radiol · 2019-07-02

该前瞻性研究纳入174例无局灶性肝病患者,在3 T行多参数MRI(含SWI、T1及T2* mapping、PDFF定量和MR弹性成像),比较不同脂肪变分级和肝硬度分组间的SWI与T2*值。结果显示SWI与T2*均显著依赖脂肪变分级(p<0.001),但SWI在区分肝纤维化分级方面优于T2*(p<0.001 vs p=0.05),两者肝肌比在区分纤维化分级上表现相似。

要点

  • SWI与T2*均显著依赖肝脏脂肪变分级(p<0.001),用于评估纤维化时需考虑脂肪变的影响。
  • SWI在区分肝纤维化分级方面优于T2*(p<0.001 vs p=0.05)。
  • SWI肝肌比与T2*肝肌比在区分肝纤维化分级上表现相似(p<0.001 vs p=0.036)。

核心结论

  • SWI和T2* mapping均强烈依赖肝脏脂肪变分级,但在多参数方法中两者都是肝纤维化的有用预测指标。

研究设计与样本

  • 前瞻性研究,纳入174例无局灶性肝病患者,在3 T行多参数MRI,包括SWI、T1及T2* mapping、质子密度脂肪分数(PDFF)定量和MR弹性成像;在肝脏4个位置及椎旁肌测量SWI、T2*和T1,计算肝肌比(LMR);以PDFF和肝硬度分组进行比较。

关键影像表现/征象

  • SWI和T2*在不同脂肪变分级组间均存在显著差异(p<0.001)。
  • SWI在区分肝纤维化分级方面优于T2*(p<0.001 vs p=0.05)。
  • SWI肝肌比(p<0.001)与T2*肝肌比(p=0.036)在区分肝纤维化分级上表现相似。

诊断标准与关键数值

  • 脂肪变分级按PDFF分为<5%、5-10%、10-20%和>20%四组。
  • 肝硬度分组为正常(<2.8 kPa)、轻度升高(2.8-3.5 kPa)和升高(>3.5 kPa)。
  • SWI、T2*和T1在肝脏4个位置及椎旁肌测量,计算肝肌比(LMR)。

临床应用与阅片要点

  • 使用SWI或T2*评估肝纤维化时,需考虑脂肪变分级对这两个参数的影响。
  • SWI在区分肝纤维化分级方面可能优于T2*,肝肌比参数两者表现相似。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To show that both susceptibility-weighted imaging (SWI) and T2*-mapping are dependent on liver steatosis, which should be taken into account when using these parameters to grade liver fibrosis and cirrhosis.

METHODS: In this prospective study, a total of 174 patients without focal liver disease underwent multiparametric MRI at 3 T including SWI, T1- and T2* mapping, proton density fat fraction (PDFF) quantification and MR elastography. SWI, T2* and T1 were measured in the liver (4 locations), as well as in paraspinal muscles, to calculate the liver-to-muscle ratio (LMR). Liver and LMR values were compared among patients with different steatosis grades (PDFF < 5%, 5-10%, 10-20% and >20%), patients with normal, slightly increased and increased liver stiffness (<2.8 kPa, 2.8-3.5 kPa and >3.5 kPa, respectively). ANOVA with Bonferroni-corrected post hoc tests as well as a multivariate analysis were used to compare values among groups and parameters.

RESULTS: SWI and T2* both differed significantly among groups with different steatosis grades (p < 0.001). However, SWI allowed a better differentiation among liver fibrosis grades (p < 0.001) than did T2* (p = 0.05). SWI LMR (p < 0.001) and T2* LMR (p = 0.036) showed a similar performance in differentiating among liver fibrosis grades.

CONCLUSION: SWI and T2*-mapping are strongly dependent on the liver steatosis grades. Nevertheless, both parameters are useful predictors for liver fibrosis when using a multiparametric approach.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Obmann VC, Marx C, Berzigotti A, et al. Liver MRI susceptibility-weighted imaging (SWI) compared to T2* mapping in the presence of steatosis and fibrosis. Eur J Radiol. 2019. PMID: 31439261. doi:10.1016/j.ejrad.2019.07.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。